AAP
23
2
AEP
62
-4
MMM
50
-2
R
67
4
EXPD
54
7
PBI
60
2
VTR
55
-2
NOV
45
3
GM
57
2
NDAQ
59
-3
AVGO
40
-24
CHD
56
-2
RF
50
3
TSCO
57
-3
URBN
32
2
VRSK
38
-2
NAVI
57
2
NTRS
49
2
ECL
72
-2
LB
52
7
AAP
23
2
AEP
62
-4
MMM
50
-2
R
67
4
EXPD
54
7
PBI
60
2
VTR
55
-2
NOV
45
3
GM
57
2
NDAQ
59
-3
AVGO
40
-24
CHD
56
-2
RF
50
3
TSCO
57
-3
URBN
32
2
VRSK
38
-2
NAVI
57
2
NTRS
49
2
ECL
72
-2
LB
52
7
Financhill
Back

Corcept Therapeutics Stock Predictions

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73

CORT
Corcept Therapeutics

Last Price:
42.21
Seasonality Move:
-0.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Hint at where the next big move in the market will be this month

Spot the next big move with this free book from a hedge fund manager

Corcept Therapeutics Stock Forecast

  • Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 28.4% based on the past 20 years of stock performance.
  • Corcept Therapeutics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
  • Is Corcept Therapeutics Stock Undervalued?
    The current Corcept Therapeutics [CORT] share price is $39.71. The Score for CORT is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Corcept Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 28.4% based on the past 20 years of stock performance.

Corcept Therapeutics Stock Rating

Buy
73
Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics overpriced?

  • Corcept Therapeutics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%

Corcept Therapeutics Stock Price History

Is CORT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com

52-Week Data

52-Week High:
41.95
52-Week Low:
20.84

Prediction Charts

Market Cap:
4.15B
Price in USD:
39.71
Volume:
1.42M
Beta:
0.85

Technical Analysis

SMA50:
34.63
SMA100:
31.81
SMA200:
28.35
52-Wk Change:
18.64%

Stock Predictions

  • Is Corcept Therapeutics stock public?
    Yes, Corcept Therapeutics is a publicly traded company.
  • What is the Corcept Therapeutics stock quote today?
    The Corcept Therapeutics stock price is 39.71 USD today.
  • How to buy Corcept Therapeutics stock online?
    You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-28 34.55 34.44 35.74 34.35
Aug-29 34.57 35.14 35.62 34.04
Aug-30 35.32 35.29 35.48 34.80
Sep-3 35.06 34.27 35.54 34.11
Sep-4 34.13 34.62 34.66 33.34
Sep-5 34.74 34.07 35.58 33.85
Sep-6 34.33 34.38 34.61 33.66
Sep-9 34.38 34.71 35.08 34.25
Sep-10 34.84 35.03 35.04 34.34
Sep-11 35.04 35.55 36.13 34.87
Sep-12 35.94 35.70 36.17 35.45
Sep-13 35.94 38.11 38.18 35.87
Sep-16 38.31 38.47 39.24 37.82
Sep-17 39.03 39.71 41.95 38.68

Corcept Therapeutics Earnings

Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Corcept Therapeutics Forecast Revenue Growth

Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.

* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.